India to Sri Lanka: Ifosfamide Export Trade Route

The India to Sri Lanka Ifosfamide corridor is one of India's established pharmaceutical export routes, with 6 shipments documented worth a combined $98.1K USD. The route is dominated by UNITED BIOTECH PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's ifosfamide manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $16.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with ifosfamide's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 28.0%, placing it at rank #13 among India's top ifosfamide export destinations globally.

On the import side, key buyers of Indian ifosfamide in Sri Lanka include BANK OF CEYLON, TRADE SERVICES DFCC BANK, HATTON NATIONAL BANK and 1 others. BANK OF CEYLON is the single largest importer with 3 shipments valued at $62.5K USD.

India's ifosfamide exports to Sri Lanka are driven primarily by a handful of large-scale manufacturers. UNITED BIOTECH PRIVATE LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Sri Lanka benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — UNITED BIOTECH PRIVATE LIMITED, GETWELL PHARMA INDIA PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $16.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharma products-ifomid-m 1g,(ifosfamidefor injection ip 1g with mesna injection200mg)bno.fmdc5b5 mfg.03/2025exp.02/2027 and ifomid-m 1gifosfamide for inj.ip 1g with mesna inj.200mgp:1g vial&3x2ml ampls1setb.no.fmdg3b7 m:7/23e:6/25, suggesting that buyers in Sri Lanka tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, BANK OF CEYLON is the largest importer with 3 shipments worth $62.5K USD — representing 64% of all ifosfamide imports from India on this route.